Pathology, Inc., a provider of anatomic pathology and molecular diagnostic testing services, has received a Series A investment led by ABS Capital Partners with participation from ORIX Venture Finance LLC that provided venture debt to the company.
The funds will be used to partially retire founding shareholders as well as support growth and invest in new technologies.
The company has named Vicki DiFrancesco as CEO and Steve Pierce as CFO.
Ms. DiFrancesco has over 30 years experience in the laboratory services industry, most recently serving as Executive Vice President of Sales and Marketing for Spectrum Laboratory Network while Mr. Pierce was CFO of US Pathology Labs, Inc. Current CEO, Alfred Lui, M. D., will become Chairman of the Board and will continue to serve, along with Eric Glassy, M. D., as one of the Medical Directors for the Company.
As a result of the financing, Mark Anderson, General Partner at ABS Capital, and John Stobo, Managing General Partner at ABS Capital, will join Pathology’s Board of Directors.
Pathology has 170 full-time employees located at two separate facilities in Torrance, California.